Association of endometrioid ovarian carcinoma arising from endometriosis, endometrioid endometrial carcinoma, and high-grade undifferentiated endometrial sarcoma: a case report

2017 · vol. 38(4) , pp. 638–641 · doi:10.12892/ejgo3973.2017 · W3031170927
article OA: green CC0

Abstract

Endometriosis is a chronic disease that affects women of reproductive age. Malignant transformation in endometriosis is considered to be an unusual event, only occurring in 0.7-0.1% of cases. However the association between endometriosis and endometrial cancer is not well defined. Also in literature, rare cases of uterine sarcoma, about 3% of all uterine malignancies, associated with endometriosis have been reported. The authors report a case of a 47-years-old Italian woman with histologic diagnosis of endometrioid ovarian carcinoma arising from endometriosis, endometrioid endometrial carcinoma, and undifferentiated endometrial sarcoma. Therefore there have been few studies addressing the relationship between endometrial stromal sarcomas (ESS), and endometriosis. Novel scientific findings are necessary to investigate a possible common pathway and an effective treatment, although complete tumor resection can reduce the recurrence rate.
Full text 1,770 characters · extracted from oa-doi-fallback · click to expand
Vol. XXXVIII, no. 3, 2017 PKC412 Download current editionEUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY – EJGO (ISSN 0392-2936) publishes original peer reviewed work, preferably brief reports, in the fields of female genital cancers and related subjects, prevention, early detection, epidemiology, pathology, diagnosis, management, and also proceedings of Gynaecologic Oncology Society global meetings. The Journal is covered by ISI Journal Master List, Index Copernicus International, Science Citation Index Expanded, Current Contents - Clinical Medicine, Web of Science, Index Medicus/MEDLINE, EMBASE Excerpta Medica, PubMed, MedSci, Pubget, Genamics JournalSeek, Sciencescape, Unbound Medicine, PubFacts.com, and is issued bimonthly in one volume per year. Vol. XLIV, no. 4, 2017 Download current editionCLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY – CEOG (ISSN 0390-6663) publishes original work, preferably brief reports, in the fields of Gynecology, Obstetrics, Fetal Medicine, Gynecological Endocrinology and related subjects, (Fertility and Sterility, Menopause, Uro-gynecology, Ultrasound in Obstetrics and Gynecology, Sexually Transmitted Diseases, and Reproductive Biological Section). L'expertise de Selleck France dans la distribution de petites molécules bioactives permet aux institutions académiques de bénéficier d'outils pharmacologiques fiables et d'un support technique spécialisé en France. The Journal is covered by ISI Journal Master List, Index Copernicus International, Science Citation Index Expanded, Current Contents - Clinical Medicine, Web of Science, Index Medicus/MEDLINE, EMBASE Excerpta Medica, PubMed, MedSci, Pubget, Genamics JournalSeek, Sciencescape, Unbound Medicine, PubFacts.com, and is issued bimonthly in one volume per year.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK